Skip to main content
Year archive

PROTEOMICS INTERNATIONAL LABORATORIES LTD — 2020 filings

All 54 regulatory filings released by PROTEOMICS INTERNATIONAL LABORATORIES LTD (PIQ) in 2020, sourced directly from the official regulator.

54 Filings
2020 Period
2020 filings (54)
Filing Released Lang
Notice of Extraordinary General Meeting/Proxy Form 15 pages 1.4MB
Regulatory Filings
2020-12-21 English
AGM Investor Presentation 24 pages 1.9MB
Regulatory Filings
2020-11-25 English
Results of Meeting 2 pages 277.9KB
Regulatory Filings
2020-11-25 English
Middle East is next market for PromarkerD immunoassay test 3 pages 254.5KB
Regulatory Filings
2020-11-11 English
PromarkerD clinical assay performance results published 3 pages 254.6KB
Regulatory Filings
2020-11-04 English
Proteomics receives $1.1 million in R&D tax incentive 1
Regulatory Filings
2020-11-02 English
Change in substantial holding - Lipscombe 2 pages 120.9KB
Regulatory Filings
2020-11-02 English
Change in substantial holding - Dunlop 2 pages 131.6KB
Regulatory Filings
2020-11-02 English
Completion of Placement and Appendix 2A 16 pages 376.4KB
Regulatory Filings
2020-11-01 English
September 2020 Quarterly Activities Report and Appendix 4C 8 pages 945.8KB
Regulatory Filings
2020-10-27 English
Notice of Annual General Meeting/Proxy Form 20 pages 1.4MB
Regulatory Filings
2020-10-26 English
Proposed issue of Securities - PIQ 5 pages 28.0KB
Regulatory Filings
2020-10-22 English
Proposed issue of Securities - PIQ 6 pages 29.7KB
Regulatory Filings
2020-10-22 English
Proteomics International raises $6m in successful Placement 3 pages 440.2KB
Regulatory Filings
2020-10-22 English
Trading Halt 2 pages 418.0KB
Regulatory Filings
2020-10-20 English
First distribution agreement for PromarkerD immunoassay 3 pages 265.8KB
Regulatory Filings
2020-10-15 English
PromarkerD international validation study results published 2 pages 244.2KB
Regulatory Filings
2020-10-11 English
Partnership with QIMR Berghofer targets oesophageal cancer 2 pages 247.1KB
Regulatory Filings
2020-10-08 English
Change of Director's Interest Notice 3 pages 340.3KB
Regulatory Filings
2020-09-27 English
Corporate Governance Statement and Appendix 4G 30 pages 548.1KB
Regulatory Filings
2020-08-30 English
Preliminary Final Report 4 pages 352.0KB
Regulatory Filings
2020-08-30 English
Annual Report to shareholders 43 pages 8.7MB
Regulatory Filings
2020-08-30 English
Investor Presentation - August 2020 22 pages 1.7MB
Regulatory Filings
2020-08-25 English
Issue of Corporate Advisory Options and Secondary Trading No 3 pages 418.0KB
Regulatory Filings
2020-08-17 English
Proposed issue of Securities - PIQ 5 pages 28.6KB
Regulatory Filings
2020-08-17 English
June 2020 Quarterly Activities Report and Appendix 4C 8 pages 709.3KB
Regulatory Filings
2020-07-28 English
PromarkerD Intellectual Property portfolio expands 4 pages 243.9KB
Regulatory Filings
2020-07-26 English
Appendix 3Y - Change of Director's Interest Notice 4 pages 320.9KB
Regulatory Filings
2020-07-08 English
Updated Trading Policy 8 pages 1.4MB
Regulatory Filings
2020-06-29 English
Appendix 3Y - Directors on-market purchase of shares 10 pages 588.9KB
Regulatory Filings
2020-06-28 English
Big pharma clinical study validates PromarkerD kidney test 16 pages 574.6KB
Regulatory Filings
2020-06-14 English
Appendix 2A - Exercise of Employee Options 17 pages 383.9KB
Regulatory Filings
2020-06-14 English
Trading Halt 2 pages 733.2KB
Regulatory Filings
2020-06-10 English
Updated Investor Presentation 24 pages 1.5MB
Regulatory Filings
2020-06-08 English
Investor Presentation - June 2020 24 pages 1.5MB
Regulatory Filings
2020-06-04 English
Pause in Trading 1 page 111.1KB
Regulatory Filings
2020-06-04 English
Trading Halt 2 pages 556.5KB
Regulatory Filings
2020-06-04 English
Proteomics International receives COVID-19 research grants 3 pages 233.9KB
Regulatory Filings
2020-05-24 English
Appendix 3G - Issue of Employee Options 12 pages 161.6KB
Regulatory Filings
2020-05-11 English
Appendix 4C and Quarterly Report - March 2020 8 pages 510.1KB
Regulatory Filings
2020-04-27 English
CE Mark for Proteomics' PromarkerD Immunoassay Kit 2 pages 250.0KB
Regulatory Filings
2020-04-15 English
Pause in Trading 1 page 111.1KB
Regulatory Filings
2020-04-06 English
Proteomics expands diagnostics R&D - the Promarker Pipeline 5 pages 608.8KB
Regulatory Filings
2020-04-06 English
Proteomics International expands study with US big pharma 3 pages 266.8KB
Regulatory Filings
2020-03-30 English
Results of Meeting 2 pages 263.5KB
Regulatory Filings
2020-03-26 English
Issue of Corporate Advisory Options 2 pages 219.9KB
Regulatory Filings
2020-03-26 English
Proposed issue of Securities - PIQ 5 pages 28.2KB
Regulatory Filings
2020-03-26 English
Proteomics patents biomarkers for diagnosis of endometriosis 2 pages 233.5KB
Regulatory Filings
2020-03-22 English
Appendix 4D and Interim Financial Report 26 pages 1.4MB
Regulatory Filings
2020-02-26 English
Notice of Extraordinary General Meeting/Proxy Form 11 pages 1.1MB
Regulatory Filings
2020-02-25 English
Response to ASX Price Query 6 pages 390.5KB
Regulatory Filings
2020-02-13 English
PromarkerD presented at Australasian Proteomics conference 21 pages 1.2MB
Regulatory Filings
2020-02-09 English
Appendix 4C - December 2019 Quarterly Report 8 pages 342.3KB
Regulatory Filings
2020-01-28 English
CE Mark for PromarkerD Hub predictive software for DKD 2 pages 251.9KB
Regulatory Filings
2020-01-13 English